Company: PSTV
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0000950170-25-047698
Chunk: 5

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 16
Chunk 5
---
arrant issued pursuant to the Securities Purchase and Exchange Agreement, dated February 13, 2025, by and among Plus Therapeutics, Inc. and the purchasers named therein
     
    8-K
    011-34375Exhibit 4.2
    02/18/2025

      4.12
    Form of Pre-Funded Warrant
     
    8-K
    011-34375Exhibit 4.1
    03/04/2025

      4.13
    Form of Series A Warrant
     
    8-K
    011-34375Exhibit 4.2
    03/04/2025

      4.14
    Form of Series B Warrant
     
    8-K
    011-34375Exhibit 4.3
    03/04/2025

105

    10.1+
    Patent and Know-How License Agreement, dated March 29, 2020, by and between Plus Therapeutics, Inc. and NanoTx, Corp.
     
    8-K
    011-34375 Exhibit 10.1
    3/30/2020

    10.2+
    Patent & Technology License Agreement, dated December 31, 2021, by and between Plus Therapeutics, Inc. and the University of Texas Health Science Center at San Antonio
     
    10-K
    011-34375 Exhibit 10.2
    2/24/2022

    10.3
    Purchase Agreement, dated August 2, 2022, by and between Lincoln Park Capital Fund, LLC and Plus Therapeutics, Inc.
     
    8-K
    011-34375 Exhibit 10.1
    08/08/2022

    10.4
    Registration Rights Agreement, dated August 2, 2022, by and between Plus Therapeutics, Inc. and Lincoln Park Capital Fund
     
    8-K
    001-34375Exhibit 10.6
    08/08/2022

    10.5#
    Amended and Restated Employment Agreement, dated March 11, 2020, by and between Marc Hedrick and Plus Therapeutics, Inc.  
     
    10-Q
    001